Results 91 to 100 of about 46,412 (225)
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells [PDF]
, 2015 Medullary thyroid cancer (MTC) is an aggressive malignancy responsible for up to 14% of all thyroid cancer-related deaths. It is characterized by point mutations in the rearranged during transfection (RET) proto-oncogene.
Barollo, Susi +11 more
core +1 more source
Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna +10 more
wiley +1 more source
Acta clinica Croatica, 1999 Medullary thyroid carcinoma (MTC) is an uncommon thyroid tumor accounting for only 3%-5% of all thyroid malignancies. Nevertheless, it has attracted a great deal of interest for its distinctive biochemical and genetic features and unique clinical associations, with a predilection for early diagnosis and an appropriate surgical approach.
Mateša, Neven +6 more
openaire +3 more sources
Atypical Presentation of a Medullary Thyroid Carcinoma Producing Acth and Serotonin
Case Reports in Oncology, 2019 Medullary carcinoma accounts for about 5% of all thyroid malignancies. The tumor may produce other hormones in addition to calcitonin that typically occurs in the presence of distant metastases.
Mariana Ferreira +4 more
doaj +1 more source
RET proto-oncogene and thyroid cancer [PDF]
, 2018 TheRET proto-oncogene has not only conclusively been identified as responsible for the three subtypes of the inherited cancer syndrome multiple endocrine neoplasia type 2 (MEN-2) but also shown to be involved in the molecular evolution of sporadic ...
Komminoth, Paul
core
Histopathology, Volume 88, Issue 7, Page 1295-1314, June 2026.Changes and new entities in the 6th edition WCT of the digestive system, including structural, molecular, and diagnostic updates to standardize terminology and improve clinical relevance. Epithelial tumours are organized by site; neuroendocrine, mesenchymal and haematolymphoid tumours have dedicated chapters, with refined grading, redefined ...
Mark J Arends +48 more
wiley +1 more source
Expression of FAS/APO 1/CD 95 in thyroid tumors.
Folia Histochemica et Cytobiologica, 2007 Using immunohistochemistry, Fas/Apo-1 protein expression was investigated in thyroid cancers of 67 patients. Thyroid biopsies from twenty eight patients with benign thyroid diseases were also examined.
Waldemar Balcerzak +5 more
doaj +1 more source
Cancer Medicine, Volume 15, Issue 5, May 2026.ABSTRACT Background Central lymph nodes metastasis (CLNM) is common in papillary thyroid. Microcarcinoma (PTMC). Whilst prophylactic central lymph node dissection (CLND) can prevent further CLNM, it remains controversial. An accurate model to predict CLNM is therefore necessary for patients with PTMC.
Tao Li +3 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 5, May 2026.This multicenter study of 827 thyroid nodules demonstrates that a targeted NGS 4‐gene panel (BRAF^V600E, TERT promoter, RET fusions, NTRK3 fusion) achieves high diagnostic accuracy (88.2%) and PPV (99.62%) for cytologically indeterminate Bethesda III–V nodules, offering a cost‐effective first‐line molecular test in China. ABSTRACT Molecular testing has
Qiong Jiao +8 more
wiley +1 more source
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal [PDF]
, 2010 The prognosis of medullary thyroid carcinoma (MTC) depends on the completeness of the first surgical treatment. To date, it is not possible to predict whether the tumor has been completely removed after surgery.
A. Colao +25 more
core +1 more source